Abiopharma

(10% Negative) Jazz Pharmaceuticals plc (JAZZ) Announces Business Combination

(10% Negative) Ocuphire Pharma Inc. (OCUP) Announces Business Combination

(85% Positive) CONMED Corporation (CNMD) Reports Q1 2026 Financial Results

(99% Neutral) Zimmer Biomet Holdings Inc (ZBH) Announces Executive Changes

(90% Positive) Aeglea BioTherapeutics Inc (was renamed to Spyre Therapeutics (SYRE)) (AGLE) Announces Enrollment Update for trial Due to Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment

SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2025

Cancer Research Institute Launches Transformative AI-Driven Immuno-Oncology Initiative Powered by 10x Genomics Technology

Co-Diagnostics JV CoSara Participates in Regional Conferences to Grow and Strengthen Distributor Relationships

Oncolytics Biotech® Announces Updated Clinical Data from GOBLET Cohort 4 Demonstrating Activity of Pelareorep Plus Atezolizumab in Third-Line Anal Cancer

Danaher CEO to Comment on Financial Performance

Jaguar Health Enters into U.S. License Agreement with Future Pak for Crofelemer, Providing up to $38 Million

Medtronic Diabetes announces FDA clearance for MiniMed Go™ Smart MDI system featuring Instinct sensor made by Abbott

InspireMD Announces Publication of the C-GUARDIANS Pivotal Trial Manuscript in the Journal of the American College of Cardiology (JACC)

(99% Neutral) CVRx Inc. (CVRX) Announces Business Combination

(90% Positive) Elutia Inc (ELUT) Announces Regulatory Update